|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06887 SUNSHINE PHARMA
Nominal 
38.000 +0.280 (+0.742%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 1,155,173 | 500,532 | 1,318,106 | 1,160,966 |
| Net Cash from / (used in) Investing Activities | -- | (483,446) | 29,794 | (1,682,992) | (1,109,599) |
| Net Cash from / (used in) Financing Activities | -- | (665,666) | (970,666) | 1,314,291 | (313,575) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 6,061 | (440,340) | 949,405 | (262,208) |
| Cash & Cash Equivalents at beginning of period | -- | 1,480,810 | 1,920,158 | 971,510 | 1,232,268 |
| Effect of Foreign Exchange Rate Changes | -- | (75) | 992 | (757) | 1,450 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,486,796 | 1,480,810 | 1,920,158 | 971,510 |
| Remarks: | Real time quote last updated: 02/09/2026 12:52 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -603,718 |
| %Change | 1201.958% |
| EPS / (LPS) | RMB -1.090 |
| NBV Per Share (¥) | RMB 6.708 |